Pediatric Primary Care Case Studies (159 page)

teams, caregiving,
5
–6

teen-specific concerns

acne,
467
–480

birth control,
427
–440

depression,
207
–220

diagnostic reasoning for,
1
–8

fatigue,
59
–72

late-preterm infants (adolescent parents),
493
–506

LGBT issues,
221
–231

PPEs,
133
–163

vaginal discharge,
441
–454

telephone consultations,
391
–395

tension-type headaches.
See
TTHs (tension-type headaches)

tetracycline,
475
t–477t

therapeutic management.
See
management

thiazolidinediones,
278

tinea corporis,
459

TODAY Study,
277

toddler-specific concerns.
See also
preschooler-specific concerns

anemia,
291
–320

diagnostic reasoning for,
1
–8

language/social delays,
27
–42

recurrent ear infections,
347
–358

topical medications

antibiotics.
See
antibiotics

corticosteroids.
See
corticosteroids

retinoids,
472
,
474
t–477t

total calcineurin inhibitors.
See
TCIs (total calcineurin inhibitors)

toxic megacolon,
395
–396

toxic synovitis.
See
TS (toxic synovitis)

toxins, environmental,
296
–299,
298
t–299t

toxoplasmosis,
235
–236

transgendered issues.
See
LGBT (lesbian, gay, bisexual, and transgendered) issues

trauma, oral,
405
–416

case presentations for,
405
–406,
411
–413

diagnosis of,
405
–414

avulsion, permanent incisors,
405
–414,
409
f

avulsion, primary incisors,
405
–414,
408
f

crown fracture, permanent incisor with/without pulp exposure,
405
–414,
410
f

history-taking,
406

PERRLA mnemonic,
407

physical examination,
406
–407

epidemiology/etiology of,
407
–411

fundamental contexts of,
405
,
414

management of,
411
–414

complications,
412
–414

educational plans,
414

follow-up visits,
414

prognosis,
411
–414

objectives for,
405

resources for,
414
–415

Treatment and Education of Autistic and Related Communication-Handicapped Children program.
See
TEACCH (Treatment and Education of Autistic and Related Communication-Handicapped Children) program

Treatment of Adolescent Depression Study.
See
TADS (Treatment of Adolescent Depression Study)

tretinoin (Retin-A, Avita),
474
t–477t

TriCeram,
460

tricyclic antidepressants,
218

trigeminal autonomic cephalalgias,
322
,
324
–328.
See also
headache

TRIGR study,
273
–274

trimethoprim-sulfamethoxazole,
421
–423,
475
t–477t

TS (toxic synovitis),
487

TTHs (tension-type headaches),
322
,
324
–328.
See also
headache

tuberculosis,
380

Turner syndrome,
507
–518

case presentation for,
507
–508,
511
–512,
514
–515

diagnosis of,
507
–512

diagnostic testing,
511

differential,
508
–511,
510
t–511t

epidemiology/etiology,
509

history-taking,
507
–508

physical examination,
508
–509

fundamental contexts for,
507
–508,
516

management of,
512
–516

AAP guidelines,
512

cardiovascular issues,
512
–513

endocrine issues,
513

follow-up visits,
515
–516

genetic issues,
514

neurocognitive issues,
513

NIH guidelines,
512

psychosocial support,
513
–514

referrals,
514
–515

Turner Syndrome Consensus Study Group guidelines,
512

objectives for,
507

resources for,
516
–517

type 1 diabetes,
273
–275,
275
t

type 2 diabetes,
269
–271,
275
t

U

United States departments and agencies

DHHS.
See
DHHS (Department of Health and Human Services)

USDA.
See
USDA (United States Department of Agriculture)

urinary urgency/incontinence (preschoolers),
417
–426

case presentation for,
417
–420,
422
,
425

diagnosis of,
417
–430

diagnostic testing,
419
,
421
–422

differential,
420

history-taking,
417
–420

physical examination,
418

UTI,
417
–425

epidemiology/etiology of,
418
–419

pathophysiology,
418

social/economic factors,
419

fundamental contexts of,
417
,
425

management of,
420
–425

complications,
425

dysfunction elimination syndrome,
422

follow-up visits,
424
–425

medications,
421
–422

patient education,
424

vesicoureteral reflux,
422
–424

objectives for,
417

resources for,
426

urine human chorionic gonadotropin testing,
428

USDA (United States Department of Agriculture),
94
–97,
438

UTI (urinary tract infection),
417
–425.
See also
urinary urgency/incontinence (preschoolers)

V

vaginal discharge (adolescents),
441
–454